Increased expression of erythropoietin receptor in human pterygial tissues

International Journal of Molecular Medicine

Volumn 20, Issue 5, 2007, Pages 699-702

  Kase, Satoru ^a   Osaki, Mitsuhiko ^b   Jin, Xue Hai ^a   Ohgami, Kazuhiro ^a   Yoshida, Kazuhiko ^a   Saito, Wataru ^a   Takahashi, Shuji ^c   Nakanishi, Katsuya ^c   Ito, Hisao ^b   Ohno, Shigeaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c Sapporo Social Insurance General Hospital   (Japan)

Author keywords

Epithelium; Erythropoietin receptor; Microvessels; Pterygium

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ARTICLE; CONJUNCTIVA; EPITHELIUM; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PTERYGIUM;

CONJUNCTIVA; EPITHELIUM; HUMANS; PTERYGIUM; RECEPTORS, ERYTHROPOIETIN;

EID: 38449094531     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kase S, Kitaichi N, Furudate N, Yoshida K and Ohno S: Increased expression of mucinous glycoprotein KL-6 in human pterygium. Br J Ophthalmol 90: 1208-1209, 2006.
2. Kase S, Osaki M, Sato I, Takahashi S, Nakanishi K, Yoshida K, Ito H and Ohno S: Immunolocalization of E-cadherin and {beta}-catenin in human pterygium. Br J Ophthalmol, 2007 Mar 14 [Epub ahead of print].
3. Kase S, Takahashi S, Sato I, Nakanishi K, Yoshida K and Ohno S: Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 91: 958-961, 2007.
4. Spandidos DA, Sourvinos G, Kiaris H and Tsamparlakis J: Microsatellite instability and loss of heterozygosity in human pterygia. Br J Ophthalmol 81: 493-496, 1997. (Pubitemid 27300076)
5. Detorakis ET, Drakonaki EE and Spandidos DA: Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 6: 35-41, 2000.
6. Detorakis ET, Sourvinos G, Tsamparlakis J and Spandidos DA: Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol 82: 1324-1328, 1998. (Pubitemid 28524132)
7. Lee GA and Hirst LW: Ocular surface squamous neoplasia. Surv Ophthalmol 39: 429-450, 1995.
8. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
9. Aspiotis M, Tsanou E, Gorezis S, Ioachim E, Skyrlas A, Stefaniotou M and Malamou-Mitsi V: Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye, 2006 Jun 23 [Epub ahead of print].
10. Fisher JW: Erythropoietin: physiology and pharmacology update. Exp Biol Med 228: 1-14, 2003.
11. Lacombe C and Mayeux P: The molecular biology of erythropoietin. Nephrol Dial Transplant 14 (suppl 2): 22-28, 1999.
12. Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP and Dewhirst MW: Erythropoietin biology in cancer. Clin Cancer Res 12: 332-339, 2006.
13. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K and Nakano Y: Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 239: 494-500, 1996.
14. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K and Verma A: Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61: 3561-3565, 2001.
15. Kase S, Yoshida K, Osaki M, Adachi H, Ito H and Ohno S: Expression of erythropoietin receptor in human Merkel cell carcinoma of the eyelid. Anticancer Res 26: 4535-4537, 2006.
16. Kumar SM, Acs G, Fang D, Herlyn M, Elder DE and Xu X: Functional erythropoietin autocrine loop in melanoma. Am J Pathol 166: 823-830, 2005.
17. Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M and Sytkowski AJ: Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 66: 135-145, 2006. (Pubitemid 43191235)
18. Lester RD, Jo M, Campana WM and Gonias SL: Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 280: 39273-39277, 2005.
19. Barnache S, Mayeux P, Payrastre B and Moreau-Gachelin F: Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts. Blood 98: 2372-2381, 2001.
20. Longmore GD and Lodish HF: An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell 67: 1089-1102, 1991.
21. Yoshimura A, Longmore G and Lodish HF: Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348: 647-649, 1990.
22. Lee JK, Song YS, Ha HS, Park JH, Kim MK, Park AJ and Kim JC: Endothelial progenitor cells in pterygium pathogenesis. Eye, 2006 May 26 [Epub ahead of print].
23. Genc S, Koroglu TF and Genc K: Erythropoietin and the nervous system. Brain Res 1000: 19-31, 2004.
24. Shein NA, Horowitz M, Alexandrovich AG, Tsenter J and Shohami E: Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab 25: 1456-1465, 2005.
25. Kase S, Saito W, Ohgami K, Yoshida K, Furudate N, Saito A, Yokoi M, Kase M and Ohno S: Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Br J Ophthalmol, 2007 May 23 [Epub ahead of print].